Resources from the same session
Should we really use PD-L1 as a selection driver in cervical cancer?
Presenter: Bradley Monk
Session: Biomarkers in clinical practice and future perspective for gynaecological cancers
Resources:
Slides
Webcast
MMR status, TMB or both: How to identify endometrial cancer patients who benefit the most from immunotherapy
Presenter: Vicky Makker
Session: Biomarkers in clinical practice and future perspective for gynaecological cancers
Resources:
Webcast
The role of MAPK pathway to select therapy in low-grade ovarian cancer
Presenter: Susana Banerjee
Session: Biomarkers in clinical practice and future perspective for gynaecological cancers
Resources:
Slides
Webcast
Live Q&A
Presenter: Bradley Monk
Session: Biomarkers in clinical practice and future perspective for gynaecological cancers
Resources:
Webcast